Dogwood Therapeutics, Inc (DWTX) vs Lite Strategy, Inc. (LITS)

Dogwood Therapeutics, Inc and Lite Strategy, Inc. are both Biotechnology companies. Dogwood Therapeutics, Inc and Lite Strategy, Inc. are of similar size ($51.0M and $48.6M). Across the 9 metrics below, Dogwood Therapeutics, Inc leads on 6 and Lite Strategy, Inc. on 3.

Valuation

Metric DWTX LITS Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.49 11.47
P/B 0.68 0.90 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 0.42 10.73
Earnings yield (658.09%) (139.13%) (28.84%)
Free cash flow yield (32.55%) (20.24%) (23.03%)

Profitability

Metric DWTX LITS Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (143.45%) (159.26%) (57.72%)
Return on assets (40.68%) (154.82%) (49.22%)
Return on invested capital (41.22%) (73.66%) 0.00%

Growth

Metric DWTX LITS Biotechnology median
Revenue growth (TTM) — 152.90% 5.64%
EPS growth (last fiscal year) 43.05% (189.51%) —
Revenue growth, 5-year CAGR — 67.75% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DWTX LITS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.89 11.53 4.73
Net debt to EBITDA 0.23 1.05 0.96

Dividend

Metric DWTX LITS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric DWTX LITS Biotechnology median
Market cap 48.61m 51.04m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack